Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-02-27

Clinical Trial Update: Role of Surgery for the Primary in Patients With Breast Cancer Stage IV. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the role of removing the primary breast tumor in patients with stage IV breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute, Thailand | Conditions: Carcinoma Breast Stage IV | Phase 3 | Status: WITHDRAWN